By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...

Rejoice, fellow vaccine enthusiasts-it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, ...

The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its ...

US biopharma Novavax (Nasdaq: NVAX) closed 20% higher on Wednesday after announcing an update on its COVID-19 vaccine. The US ...

Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday. The news sent company shares ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

Whooping cough cases are rising, and doctors are bracing for yet another tough year. There have been 8,485 cases reported in ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

The COVID vaccine brought a renewed public debate around vaccines. A new film airing on PBS explores the politicization of ...

Parcel giant UPS said on Thursday it would buy Canada's Andlauer Healthcare Group in an all-cash deal valued at $1.6 billion, ...